Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD

3.610

0.00 (0.00%)

At close: May 17, 2024, 4:00 PM

3.530

-0.080 (-2.22%)

After-hours: May 17, 2024, 6:42 PM EDT

Elevation Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-45.7	-95.08	-32.04	-17.27	-5.88
Depreciation & Amortization	0.04	0.03	0.02	0.02	0
Share-Based Compensation	3.34	3.21	1.57	0.05	0.01
Other Operating Activities	-13.85	6.36	0.28	4.9	0.42
Operating Cash Flow	-56.18	-85.48	-30.17	-12.3	-5.45
Capital Expenditures	0	-0.09	0	-0.07	0
Change in Investments	11.54	-44.31	0	0	0
Investing Cash Flow	11.54	-44.4	0	-0.07	0
Share Issuance / Repurchase	46.48	-0.04	97.06	0.02	0
Debt Issued / Paid	0	29.53	0	0	0
Other Financing Activities	1.5	0.02	-0.01	90.01	7.19
Financing Cash Flow	47.98	29.51	97.05	90.03	7.19
Net Cash Flow	3.34	-100.37	66.88	77.66	1.74
Free Cash Flow	-56.18	-85.57	-30.17	-12.37	-5.45
Free Cash Flow Per Share	-1.65	-3.68	-2.49	-15.62	-7.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).